Skip to main content
. Author manuscript; available in PMC: 2010 Mar 15.
Published in final edited form as: J Urol. 2009 Jan 23;181(3):1104–1113. doi: 10.1016/j.juro.2008.11.026

Fig 3.

Fig 3

A Kaplan-Meier graph showing times to PSA-based progression between thalidomide (°) and placebo (*) during oral phase A. The median time for thalidomide was 15 months compared to 9.6 months for placebo, P=0.21.